-
Mashup Score: 1Loader - 9 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Loader - 26 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Loader - 1 month(s) ago
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
The U.S. Food and Drug Administration #FDA has approved Ultomiris (ravulizumab-cwvz) for the treatment of adult patients with Neuromyelitis Optica Spectrum Disorder #NMOSD that tests positive for anti-aquaporin-4 #CheckRare #RareDisease https://t.co/hztL6Kw2v7